Research and Markets: Competitor Analysis: Ebola Virus Vaccines and Therapeutics Report 2014 Featuring Over 30 Institutions

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/n7fs7d/competitor) has announced the addition of the "Competitor Analysis: Ebola Virus Vaccines and Therapeutics" report to their offering.

The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections provides a competitor evaluation in the field of new molecules for prevention or treatment of Ebola virus infections as of October 2014.

Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of therapeutic antibodies, immunoglobulins, RNA, proteins, vaccines and small molecules for prevention and treatment of Ebola virus infections. In addition, the report lists company-specific R&D pipelines of Ebola virus vaccines and therapeutics.

Competitor projects are listed in a tabular format providing information on:

  • Drug Codes
  • Target / Mechanism of Action
  • Class of Compound
  • Company
  • Product Category
  • Indication
  • R&D Stage

Key Topics Covered:

1. Ebola Virus Vaccines

2. Ebola Virus Therapeutics

3. Corporate Ebola Virus Vaccines & Therapeutics R&D Pipeline

Companies Mentioned

  • Bavarian Nordic
  • Biocryst Pharmaceuticals
  • Chimerix
  • Defyrus
  • Fab'entech
  • Fujifilm Holdings
  • GlaxoSmithKline (Wellcome Trust; Okairos)
  • Hemispherx
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Ivanov Institute (of Russian Health Ministry)
  • Johnson & Johnson (Crucell)
  • LeafBio
  • Mapp Biopharmaceuticals
  • MediVector
  • Mitsubishi Tanabe Pharma (Medicago)
  • Nanoviricides
  • National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID)
  • NewLink Genetics (BioProtection Systems)
  • Novartis
  • Pentamer Pharmaceuticals
  • Profectus Biosciences
  • Public Health Agency of Canada
  • Sarepta Therapeutics
  • Tekmira
  • Thomas Jefferson University
  • United States Army Medical Research Institute for Infectious Diseases (USAMRIID)
  • US Department of Defense's Defense Threat Reduction Agency (DTRA)
  • Vaxart
  • Walter Reed Army Institute of Research (WRAIR)

For more information visit http://www.researchandmarkets.com/research/n7fs7d/competitor

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Infectious Diseases